Clinical studies recruiting near Wroclaw

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg · Pfizer · NCT05020236 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Dobrostan · Philip Morris Products S.A. · NCT07108166 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 6160005 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · POLIMED CLINIC Sp. z o.o. · Pfizer · NCT07028853 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · PlanetMed Sp. z o.o. · Boehringer Ingelheim · NCT06636656 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Uniwersytecki Szpital Kliniczny - Klinika Hematologii, Terap · Miltenyi Biomedicine GmbH · NCT04844866 Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Followin
Phase 3 · Wroclaw Medical University · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi · NCT07195149 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak · H. Lundbeck A/S · NCT05897320 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · dermMedica Sp. z o.o. · Takeda · NCT07108283 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Reum-Medica s.c. Bozena Kowalewska, Marek Zawadzki · Takeda · NCT06671496 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 6160002 · Sanofi · NCT07190196 Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Defici
Phase 4 · Uniwersytecki Szpital kliniczny im. Jana Mikulicza-Radeckieg · Wroclaw Medical University · NCT05759078 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Dolnoslaskie Centrum Chorob Pluc · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0125 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0021 · Bristol-Myers Squibb · NCT07291076 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · 4 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ we Wroclawi · Amgen · NCT07037433 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · MIGRE Polskie Centrum Leczenia Migreny, Merz Investigational · Merz Therapeutics GmbH · NCT07018700 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak SpAA · Takeda · NCT07244263 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckieg · Bayer · NCT07192952 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg · Eli Lilly and Company · NCT07222332 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Uniwersytecki Szpital Kliniczny · Regeneron Pharmaceuticals · NCT06091865 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 6160002 · Sanofi · NCT06958536 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · Pratia Onkologia Wrocław · CatalYm GmbH · NCT07112196 Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.
NA · Department of Nephrology and Transplantation Medicine · Wroclaw Medical University · NCT06550479 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Melita Medical · Eli Lilly and Company · NCT06937086

Look up another city

Look up another condition